Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashini Fox

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of STD & AIDS|May 12, 2018
Lymphogranuloma venereum: a rare and forgotten cause of rectal stricture formationLeia Craxford, Ashini Fox
Plos One|April 30, 2015
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent IndividualsAnnette Pachnio, Jusnara Begum, Ashini Fox, et al.
Sexual Health|August 3, 2022
Why sexual health clinics are important in the 2020sNicholas A Medland, Ruth Taylor, John Saunders, et al.
HIV Medicine|September 11, 2024
CROI 2024 BHIVA working group summaryTristan J Barber, Amanda Clarke, Ashini Fox, et al.
International Journal of STD & AIDS|June 22, 2021
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimensChinyere Okoli, Achim Schwenk, Matthew Radford, et al.
Plos One|July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver diseaseDaniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of STD & AIDS|May 12, 2018
Lymphogranuloma venereum: a rare and forgotten cause of rectal stricture formationLeia Craxford, Ashini Fox
Plos One|April 30, 2015
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent IndividualsAnnette Pachnio, Jusnara Begum, Ashini Fox, et al.
Sexual Health|August 3, 2022
Why sexual health clinics are important in the 2020sNicholas A Medland, Ruth Taylor, John Saunders, et al.
HIV Medicine|September 11, 2024
CROI 2024 BHIVA working group summaryTristan J Barber, Amanda Clarke, Ashini Fox, et al.
International Journal of STD & AIDS|June 22, 2021
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimensChinyere Okoli, Achim Schwenk, Matthew Radford, et al.
Plos One|July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver diseaseDaniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Pageof 1